Corona Remedies Current Share Price | Corona Remedies Stock Screener
CORONA
Pharmaceuticals
Corona Remedies Current Stock Price Today
Live Share Price NSE
₹2200.80
▲
3.60 (0.16%)
Live Share Price BSE
₹2200.15
▲
10.85 (0.50%)
As of September 10, 2026, the live Corona Remedies share price (NSE: CORONA) is ₹2,200.80 on NSE and ₹2,200.15 on BSE, up 0.16% from the previous close, with shares trading between ₹2,060.50 and ₹2,225.00 in today's trading session, and a 52-week range of ₹1,347.70–₹2,200.80.
Browse CORONA complete financial statements to support your investment research.
Use the Corona Remedies stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Corona Remedies Market Cap
₹12,802.00 Cr.
CORONA P/E Ratio (TTM)
64.12
Corona Remedies P/B Ratio
17.09
EPS (TTM)
₹30.27
Dividend Yield
0.48%
Debt to Equity
0.19
CORONA 52 Week High
₹2200.80
Corona Remedies 52 Week Low
₹1347.70
Operating Margin
22.00%
Profit Margin
14.08%
CORONA Revenue (TTM)
₹426.00
EBITDA
₹96.00
Net Income
₹60.00
Total Assets
₹1,205.00
Total Equity
₹747.00
Corona Remedies Current Share Price Chart
Track the current Corona Remedies share price and stock price with an interactive chart. Analyse CORONA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Corona Remedies stock quote in one place.
Corona Remedies Company Profile - Fundamental Screener
Screen Corona Remedies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for CORONA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE02ZQ01018
Corona Remedies Balance Sheet Screener
Screen CORONA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 1,205 | 930 | 831 | 595 |
| Current Assets | 348 | 339 | 290 | 292 |
| Fixed Assets | 554 | 370 | 384 | 185 |
| Liabilities | ||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 97 | 84 | 126 | 49 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 747 | 606 | 480 | 409 |
| Share Capital | 61 | 61 | 61 | 61 |
| Reserves & Surplus | 686 | 545 | 419 | 347 |
Corona Remedies Income Statement Screener - Profit & Revenue Analysis
Screen Corona Remedies income statement and profit fundamentals.
Analyze CORONA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Corona Remedies share price evaluation.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 426 | 358 | 345 | 364 | 349 | 295 | 299 | 316 | 293 |
| Expenses | 329 | 291 | 278 | 283 | 277 | 240 | 228 | 247 | 242 |
| EBITDA | 96 | 66 | 66 | 81 | 72 | 56 | 70 | 69 | 51 |
| Operating Profit % | 22.00% | 18.00% | 19.00% | 22.00% | 20.00% | 18.00% | 23.00% | 21.00% | 17.00% |
| Depreciation | 13 | 10 | 9 | 9 | 9 | 10 | 10 | 9 | 8 |
| Interest | 3 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 |
| Profit Before Tax | 80 | 55 | 55 | 70 | 61 | 44 | 58 | 57 | 39 |
| Tax | 20 | 9 | 14 | 18 | 15 | 12 | 13 | 14 | 9 |
| Net Profit | 60 | 45 | 41 | 52 | 46 | 32 | 45 | 43 | 30 |
| EPS | 9.83 | 7.41 | 6.75 | 8.55 | 7.55 | 5.16 | 7.35 | 7.03 | 4.90 |
Corona Remedies Cash Flow Screener - Liquidity Fundamentals
Screen CORONA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March |
|---|---|---|---|---|
| Operating Activities | 230 | 191 | 157 | 103 |
| Investing Activities | -256 | -84 | -267 | -50 |
| Financing Activities | 25 | -107 | 99 | -45 |
| Net Cash Flow | -1 | 0 | -11 | 8 |
Corona Remedies Shareholding Pattern Screener
See Corona Remedies shareholding pattern with promoter, FII, and DII holdings.
Check Corona Remedies promoter holding and ownership changes for CORONA on TickJournal.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Apr |
|---|---|---|---|---|
| Promoter Holding | 69.00% | 69.00% | 69.00% | 72.50% |
| FII Holding | 3.63% | 2.25% | 1.84% | 0.00% |
| DII Holding | 12.90% | 7.02% | 6.76% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 0.89% | 0.77% | 1.36% | 0.00% |
| Other Holding | 13.58% | 20.97% | 21.05% | 27.50% |
| Shareholder Count | 20,185 | 19,609 | 9 | 9 |
Corona Remedies Share Dividend Screener - Share Yield Analysis
Check Corona Remedies dividend history with payout and yield data.
View Corona Remedies dividend details including ex-dates and amounts for CORONA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹10.00 | 0.48% |
| 2025-March | ₹7.31 | 0.47% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Corona Remedies Stock Index Membership
See which indices include Corona Remedies stock.
Check CORONA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Corona Remedies Market Events Screener - Corporate Actions
Get Corona Remedies corporate actions including splits, bonuses, and buybacks.
Check Corona Remedies stock events that may affect CORONA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-07-31 | 2026-07-31 | Quarterly Result Announcement | NA | 1.27% |
| 2026-07-09 | 2026-07-09 | Annual General Meeting | NA | 14.52% |
| 2026-06-19 | 2026-06-19 | Dividend | ₹ 10.00 /share | 7.04% |
| 2026-05-11 | 2026-05-11 | Quarterly Result Announcement | NA | 1.36% |
| 2026-02-02 | 2026-02-02 | Quarterly Result Announcement | NA | 3.06% |
| 2026-01-02 | 2026-01-02 | Quarterly Result Announcement | NA | 4.10% |
Corona Remedies Competitors Screener - Peer Comparison
Screen CORONA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 452,491 | 37.25 | 61,674 | 12.69% | 11,565 | 42.08 |
| Divis Laboratories | 254,186 | 86.86 | 11,067 | 13.95% | 2,568 | 73.44 |
| Torrent Pharmaceuticals | 188,663 | 87.56 | 13,886 | 20.34% | 2,138 | 51.61 |
| Zydus Life Science | 115,264 | 24.98 | 27,658 | 17.64% | 5,026 | 50.98 |
| Cipla | 111,806 | 33.32 | 29,045 | 2.24% | 3,870 | 37.48 |
| Laurus Labs | 105,105 | 96.41 | 6,868 | 22.01% | 890 | 66.90 |
| Aurobindo Pharma | 97,354 | 26.14 | 34,145 | 5.56% | 3,503 | 60.75 |
| Lupin | 96,234 | 17.40 | 29,039 | 26.75% | 5,356 | 25.42 |
| Dr Reddys Laboratories | 96,070 | 30.19 | 35,059 | 3.90% | 4,158 | 40.13 |
| Mankind Pharma | 95,361 | 46.06 | 14,636 | 14.85% | 1,938 | 36.72 |
Corona Remedies Company Announcements - News Screener
Screen CORONA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-20 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-08-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-08-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-08-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-07-31 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-07-31 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-07-31 | Unaudited Financial Results For The First Quarter And Three Months Ended June 30 2026 | - |
| 2026-07-31 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-07-22 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-07-17 | Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results On Standalone And Consolidated Basis For First Quarter And Three Months Ended June 30 2026 | - |
| 2026-07-10 | Shareholders Meeting / Postal Ballot- Scrutinizers Report | - |
| 2026-07-09 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-07-06 | Compliances-Certificate Under Reg. 74(5) Of SEBI (DP) Regulations 2018 | - |
| 2026-06-30 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-06-30 | Commencement Of Commercial Production | - |
| 2026-06-29 | Closure of Trading Window | - |
| 2026-06-19 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-06-19 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-06-19 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |